ClinicalTrials.Veeva

Menu

Understand FoG in PD: Behavioral Physiology and Clinical Application

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Freezing of Gait
Parkinson Disease

Treatments

Behavioral: Clinical evaluations

Study type

Interventional

Funder types

Other

Identifiers

NCT02987140
201606057RINA

Details and patient eligibility

About

The overall goals of this proposed study are to investigate the behavioral and neurophysiological mechanisms of patients with Parkinson's disease (PD) experiencing freezing of gait (FoG). More specifically, we aim to determine the behavioral changes in context-dependency and changes in corticomotor excitability associated with FoG.

Full description

Background: Freezing of gait (FoG) is a debilitating symptom for patients with Parkinson's disease (PD). FoG not only impairs walking but also significantly increase fall risks and decrease quality of life for patients with PD. Despite the critical consequences, the mechanisms associated with this phenomenon are not well understood.

Clinically, FoG often occurs when individuals with PD are approaching a narrow pathway or crossing a busy street. This observation leads to the hypothesis that FoG is associated with context-dependent motor performance, a phenomenon that an individual demonstrate poorer performance if the learned motor task is carried out in an unfamiliar context. Whether the occurrence of freezing episodes is a result of context-dependency has not been systematically investigated. Moreover, the changes in corticomotor excitability associated with FoG have not been well-established.

Objectives: The objectives of this proposal are to understand the behavioral and neurophysiological mechanisms of FoG. The specific aim is to examine the behavioral changes in context-dependency and changes in corticomotor excitability associated with FoG.

Methods: a total of 70 participants, including PD patients with FoG, PD patients without FoG, and age-matched non-disabled adults, will be recruited. The participants will undergo behavioral and neurophysiological examinations. Behavioral evaluations will include context-dependent motor performance, FoG, disease severity, and walking and balance functions. Transcranial magnetic stimulation and electroencephalogram will be used to measure corticomotor excitability of the participants. Analysis of variance (ANOVA) and regression analysis will be performed to compare and determine the relationship between FoG, behavioral outcomes, and corticomotor excitability. Statistical significance level is set at p < 0.05.

Enrollment

70 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Individuals with Parkinson's disease
  • Healthy control subjects

Exclusion criteria

  • unable to follow the instructions
  • have other neurological diseases other than PD
  • have pacemaker implanted in their body
  • have a history of seizure
  • have a family history of epilepsy

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

70 participants in 3 patient groups

PD+FoG
Experimental group
Description:
PD patients with FoG
Treatment:
Behavioral: Clinical evaluations
PD-FoG
Active Comparator group
Description:
PD patients without FoG
Treatment:
Behavioral: Clinical evaluations
Control
Active Comparator group
Description:
age-matched non-disabled adults
Treatment:
Behavioral: Clinical evaluations

Trial contacts and locations

1

Loading...

Central trial contact

Ya-Yun Lee, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems